Select Medical Holdings Co. (SEM) To Go Ex-Dividend on March 3rd

Select Medical Holdings Co. (NYSE:SEM) announced a quarterly dividend on Thursday, February 13th, Wall Street Journal reports. Stockholders of record on Monday, March 3rd will be given a dividend of 0.0625 per share by the health services provider on Thursday, March 13th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Monday, March 3rd.

Select Medical has raised its dividend payment by an average of 10.1% annually over the last three years. Select Medical has a dividend payout ratio of 17.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Select Medical to earn $1.41 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 17.7%.

Select Medical Trading Down 1.5 %

Shares of NYSE:SEM opened at $18.19 on Friday. The stock has a market capitalization of $2.35 billion, a PE ratio of 11.02, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. The company’s 50-day moving average price is $19.06 and its two-hundred day moving average price is $27.48. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical has a one year low of $16.20 and a one year high of $40.98.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion. On average, equities analysts forecast that Select Medical will post 1.17 EPS for the current fiscal year.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 17.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently commented on SEM. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Royal Bank of Canada lowered their target price on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a report on Monday, February 24th. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Monday, February 24th. Finally, UBS Group lowered their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $27.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.